OBI Pharma (4174) — Working Capital to Net Assets Ratio
OBI Pharma (4174) has a Working Capital to Net Assets ratio of 49.5% as of September 2025. Working capital of NT$1.53 Billion (current assets of NT$1.90 Billion minus current liabilities of NT$371.47 Million) is measured against net assets of NT$3.08 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See OBI Pharma balance sheet quality to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
OBI Pharma Working Capital to Net Assets (2011–2024)
This chart shows how OBI Pharma's Working Capital to Net Assets ratio has evolved across 14 annual periods from 2011 to 2024. As of September 2025, the ratio stands at 49.5%, reflecting working capital of NT$1.53 Billion against net assets of NT$3.08 Billion TWD. Check OBI Pharma (4174) tangible net worth to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for OBI Pharma (2011–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for OBI Pharma from 2011 to 2024, covering 14 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see OBI Pharma (4174) market capitalisation.
| Year | WC/NA Ratio | Working Capital (TWD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 62.8% | NT$3.03 Billion | NT$4.82 Billion | NT$3.44 Billion | NT$412.37 Million | ▲ +2.2 pp |
| 2023 | 60.6% | NT$3.00 Billion | NT$4.95 Billion | NT$3.16 Billion | NT$158.62 Million | ▼ -17.8 pp |
| 2022 | 78.4% | NT$4.81 Billion | NT$6.14 Billion | NT$5.03 Billion | NT$221.14 Million | ▲ +13.2 pp |
| 2021 | 65.3% | NT$2.53 Billion | NT$3.87 Billion | NT$2.85 Billion | NT$327.22 Million | ▼ -10.1 pp |
| 2020 | 75.4% | NT$3.65 Billion | NT$4.84 Billion | NT$3.89 Billion | NT$248.49 Million | ▼ -11.2 pp |
| 2019 | 86.6% | NT$4.51 Billion | NT$5.20 Billion | NT$4.71 Billion | NT$200.00 Million | ▲ +4.1 pp |
| 2018 | 82.5% | NT$3.69 Billion | NT$4.47 Billion | NT$3.79 Billion | NT$103.82 Million | ▼ -9.3 pp |
| 2017 | 91.8% | NT$4.64 Billion | NT$5.06 Billion | NT$4.71 Billion | NT$68.65 Million | ▲ +30.4 pp |
| 2016 | 61.4% | NT$3.78 Billion | NT$6.16 Billion | NT$3.88 Billion | NT$97.46 Million | ▲ +30.3 pp |
| 2015 | 31.1% | NT$2.23 Billion | NT$7.18 Billion | NT$2.36 Billion | NT$127.00 Million | ▼ -30.8 pp |
| 2014 | 61.9% | NT$893.11 Million | NT$1.44 Billion | NT$937.35 Million | NT$44.24 Million | ▼ -3.6 pp |
| 2013 | 65.4% | NT$1.26 Billion | NT$1.93 Billion | NT$1.30 Billion | NT$41.46 Million | ▼ -23.2 pp |
| 2012 | 88.6% | NT$735.41 Million | NT$829.77 Million | NT$779.82 Million | NT$44.40 Million | ▲ +0.4 pp |
| 2011 | 88.2% | NT$448.51 Million | NT$508.44 Million | NT$462.78 Million | NT$14.27 Million | — |